Binding Studies and Lead Generation of Pteridin-7(8 H)-one Derivatives Targeting FLT3

Int J Mol Sci. 2022 Jul 12;23(14):7696. doi: 10.3390/ijms23147696.

Abstract

Ligand modification by substituting chemical groups within the binding pocket is a popular strategy for kinase drug development. In this study, a series of pteridin-7(8H)-one derivatives targeting wild-type FMS-like tyrosine kinase-3 (FLT3) and its D835Y mutant (FL3D835Y) were studied using a combination of molecular modeling techniques, such as docking, molecular dynamics (MD), binding energy calculation, and three-dimensional quantitative structure-activity relationship (3D-QSAR) studies. We determined the protein-ligand binding affinity by employing molecular mechanics Poisson-Boltzmann/generalized Born surface area (MM-PB/GBSA), fast pulling ligand (FPL) simulation, linear interaction energy (LIE), umbrella sampling (US), and free energy perturbation (FEP) scoring functions. The structure-activity relationship (SAR) study was conducted using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA), and the results were emphasized as a SAR scheme. In both the CoMFA and CoMSIA models, satisfactory correlation statistics were obtained between the observed and predicted inhibitory activity. The MD and SAR models were co-utilized to design several new compounds, and their inhibitory activities were anticipated using the CoMSIA model. The designed compounds with higher predicted pIC50 values than the most active compound were carried out for binding free energy evaluation to wild-type and mutant receptors using MM-PB/GBSA, LIE, and FEP methods.

Keywords: 3D-QSAR; FMS-like tyrosine kinase-3; MM-PB/GBSA; free energy perturbation; linear interaction energy; structure–activity relationship; umbrella sampling.

MeSH terms

  • Binding Sites
  • Ligands
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • Protein Binding
  • Pteridines*
  • Quantitative Structure-Activity Relationship
  • fms-Like Tyrosine Kinase 3* / genetics

Substances

  • Ligands
  • Pteridines
  • fms-Like Tyrosine Kinase 3

Grants and funding

This study was supported by the research funds from Chosun University 2022.